IOBTQ · IO Biotech, Inc.
$0.00
0.00 (-90.00%)
At close · Aug 17
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has concluded that the aforementioned conditions, among others, raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date the financial statements are issued and therefore, the Company may not be able to continue its currently ongoing research and development activities as planned and realize its assets and satisfy its liabilities in the normal course of business.”View the 10-Q filed Nov 14, 2025
Market Cap
$143,897
Shares
71.95M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.00
Open$0.00
Day$0.00–0.00
52W close$0.00–2.09
Avg vol 30d271K
Short int471K · 0.7% float · 1.7d
Short vol42%
Last earningsNov 14, 2025
DataNov 2021–Aug 2026
Filing10-Q · Nov 14
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Nov 14, 2025
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−100%
below
Price vs 50-day avg
−95%
below
RSI (14)
37
neutral
MACD trend
Positive
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−96%
trailing
6-month return
−100%
trailing
YTD return
−100%
this year
Relative strength
−112%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-45% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.65% of float · ▼ -4.2% MoM · 1.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
12 holders — near 3-yr low, contrarian setup
Squeeze score
23
low risk · 0–100
Fundamentals
EPS growth
+27%
Y/Y
Free cash flow
$-82.4M
Balance sheet
$60.0M
net cash
Quant / Vol
risk profile
Volatility
1946%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
850.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−100%
Bearish
Price vs 50-day avg
−95%
Bearish
RSI (14)
37
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-45% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.65% of float · ▼ -4.2% MoM · 1.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
12 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $2
vs 200-day avg -100%
vs 50-day avg -95%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IOBTQ
this stock
IO Biotech, Inc.
|
$143,897 | -100.0% | — | — | 0.7% |
|
ONC
BeOne Medicines Ltd.
|
$535.83B | +19.3% | +22179.2% | 823.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +13.7% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.4% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +17.5% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IOBTQ | +100.0% | -96.1% | -100.0% | +0.0% | -100.0% |
| SPY | -0.1% | +4.1% | +12.4% | +3.4% | +13.3% |
| vs SPY | +100.1% | -100.2% | -112.4% | -3.4% | -113.3% |